Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885825 | ISIN: US4525253062 | Ticker-Symbol: IUL
Frankfurt
24.04.25
08:02 Uhr
4,740 Euro
-0,120
-2,47 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IMMUCELL CORPORATION Chart 1 Jahr
5-Tage-Chart
IMMUCELL CORPORATION 5-Tage-Chart

Aktuelle News zur IMMUCELL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.04.ImmuCell reports record sales in first quarter of 20251
08.04.ImmuCell verzeichnet Rekordumsatz im ersten Quartal 20252
08.04.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025399PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
07.04.IMMUCELL CORP /DE/ - 8-K, Current Report1
07.04.ImmuCell Hires Timothy Fiori As CFO-
IMMUCELL Aktie jetzt für 0€ handeln
07.04.ImmuCell appoints new CFO to bolster growth strategy1
07.04.ImmuCell Corporation: ImmuCell Hires Chief Financial Officer86PORTLAND, Maine, April 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
02.04.ImmuCell Corporation: ImmuCell Announces Initiation of Investigational Product Use of Re-Tain78PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
28.03.IMMUCELL CORP /DE/ - 10-K, Annual Report3
25.02.ImmuCell GAAP EPS of $0.06, revenue of $7.75M1
25.02.ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024114PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
25.02.IMMUCELL CORP /DE/ - 8-K, Current Report-
20.02.ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 20241
16.01.ImmuCell settles insurance claim for production losses1
16.01.ImmuCell erzielt Einigung bei Versicherungsanspruch für Produktionsverluste1
16.01.ImmuCell Corporation: ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses270PORTLAND, Maine, Jan. 16, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
10.01.IMMUCELL CORP /DE/ - 8-K, Current Report-
09.01.ImmuCell reports higher prelim Q4 sales1
09.01.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024533PORTLAND, Maine, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
09.12.24IMMUCELL CORP /DE/ - 8-K, Current Report-
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1